The N3RO trial: A randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants <29 weeks' gestation

由 Collins, C.T, Gibson, R.A, Makrides, M, McPhee, A.J, Sullivan, T.R, Davis, P.G, Thio, M, Simmer, K, Rajadurai, V.S, Ryan, P, Morris, S, Stark, M, Travadi, J, Wright, I, Tan, K, Holberton, J, Opie, G, Callander, I, Stack, J, Shein, D, Bellhouse, S, Bolisetty, S, Lui, K, Liley, H, Berry, M, Harris, D, Chua, M.C, Agarwal, P, The N3RO Investigative Te
出版 2020